Nacuity Pharmaceuticals

Fort Worth, TX · Founded 2017 · Privately Held (backing)

Operator of a biotechnology company intended to offer treatments for retinitis pigmentosa and other ophthalmological disorders. Nacuity Pharmaceuticals is based in Fort Worth, TX and was founded in 2017. Its last reported valuation was $52 million in Jun 2022. It has raised $40.6 million across 4 recorded rounds; the latest was an $8.4 million early-stage round in Dec 2025.

Last reported valuation
$52.0M
Oct 2026
Priced at
—
Total raised
$40.6M
Last round
Early Stage VC
Dec 2025

Who backs Nacuity Pharmaceuticals?

5 investors
InvestorType
Foundation Fighting Blindness-National Neurovision Research Institute—
HSC Next—
Johns Hopkins Technology Ventures—
Retinal Degeneration Fund—
Tarnagulla Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Nacuity Pharmaceuticals investors

5 investors are on record for Nacuity Pharmaceuticals, including Foundation Fighting Blindness-National Neurovision Research Institute, HSC Next, Johns Hopkins Technology Ventures and Retinal Degeneration Fund. The early-stage round in Dec 2025 drew 98 investors.

Free account
More of Nacuity Pharmaceuticals with a free account
  • ·Watch Nacuity Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Nacuity Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View